Unit of Otolaryngology - Integrated Therapies in Otolaryngology, Campus Bio-Medico University, Rome, Italy.
Unit of Otolaryngology, University of Foggia, Italy.
J Laryngol Otol. 2021 Aug;135(8):660-667. doi: 10.1017/S0022215121001535. Epub 2021 Jul 5.
Sodium 2-mercaptoethanesulfonate (Mesna) has been proposed as a chemical aid in any surgical procedure, including cholesteatoma surgery. This review investigated the benefits and safety of Mesna during surgical management of cholesteatoma and adhesive otitis media.
A systematic literature review was performed to identify clinical studies evaluating topical Mesna application during ear surgery (cholesteatoma or atelectasis). A qualitative analysis based on data extracted was conducted.
From 27 articles, 5 retrospective studies were selected for a full analysis for a total of 607 patients (aged 5 to 72 years). Three studies evaluated cholesteatoma recidivism after Mesna application during cholesteatoma surgery, one study evaluated the surgical success rate of Mesna application for the treatment of atelectatic ears and adhesive otitis media, and one study evaluated potential ototoxicity of Mesna during cholesteatoma surgery. All the studies showed overall improvement in recurrence and residual cholesteatoma disease after Mesna application during surgery. Sensorineural hearing loss was not encountered after Mesna application.
Mesna application in cholesteatoma surgery could represent a valid and safe support tool during surgical treatment carried out both with microscopy and endoscopy. More studies are required to confirm these promising results.
巯基乙磺酸(Mesna)已被提议作为任何外科手术(包括胆脂瘤手术)中的化学辅助剂。本综述研究了 Mesna 在胆脂瘤和粘连性中耳炎的手术治疗中的益处和安全性。
进行了系统的文献综述,以确定评估耳部手术(胆脂瘤或耳咽管闭塞)期间局部应用 Mesna 的临床研究。根据提取的数据进行了定性分析。
从 27 篇文章中,选择了 5 项回顾性研究进行全面分析,共有 607 名患者(年龄 5 至 72 岁)。三项研究评估了 Mesna 在胆脂瘤手术期间应用后胆脂瘤复发的情况,一项研究评估了 Mesna 应用治疗耳咽管闭塞和粘连性中耳炎的手术成功率,一项研究评估了 Mesna 在胆脂瘤手术期间的潜在耳毒性。所有研究均表明,在手术期间应用 Mesna 后,总体上改善了复发和残留的胆脂瘤疾病。应用 Mesna 后未发生感音神经性听力损失。
Mesna 在胆脂瘤手术中的应用可能是显微镜和内窥镜手术治疗的有效且安全的辅助工具。需要更多的研究来证实这些有前途的结果。